Logo image of DGNX

DIGINEX LTD (DGNX) Stock Fundamental Analysis

NASDAQ:DGNX - Nasdaq - KYG286871044 - Common Stock - Currency: USD

54.13  -5.97 (-9.93%)

Premarket: 57 +2.87 (+5.3%)

Fundamental Rating

0

Overall DGNX gets a fundamental rating of 0 out of 10. We evaluated DGNX against 281 industry peers in the Software industry. DGNX has a bad profitability rating. Also its financial health evaluation is rather negative. DGNX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DGNX had negative earnings in the past year.
In the past year DGNX has reported a negative cash flow from operations.
DGNX Yearly Net Income VS EBIT VS OCF VS FCFDGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -565.67%, DGNX is doing worse than 96.44% of the companies in the same industry.
Industry RankSector Rank
ROA -565.67%
ROE N/A
ROIC N/A
ROA(3y)-602.33%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DGNX Yearly ROA, ROE, ROICDGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

DGNX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DGNX Yearly Profit, Operating, Gross MarginsDGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -200 -400 -600 -800 -1K

More info and screens

0

2. Health

2.1 Basic Checks

DGNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
DGNX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, DGNX has a worse debt to assets ratio.
DGNX Yearly Shares OutstandingDGNX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
DGNX Yearly Total Debt VS Total AssetsDGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -26.28, we must say that DGNX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -26.28, DGNX is doing worse than 93.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -26.28
ROIC/WACCN/A
WACC12.74%
DGNX Yearly LT Debt VS Equity VS FCFDGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 0.07 indicates that DGNX may have some problems paying its short term obligations.
The Current ratio of DGNX (0.07) is worse than 96.80% of its industry peers.
DGNX has a Quick Ratio of 0.07. This is a bad value and indicates that DGNX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DGNX (0.07) is worse than 96.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
DGNX Yearly Current Assets VS Current LiabilitesDGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.38% over the past year.
Looking at the last year, DGNX shows a very negative growth in Revenue. The Revenue has decreased by -20.07% in the last year.
EPS 1Y (TTM)47.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.25%
Revenue 1Y (TTM)-20.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-19.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DGNX Yearly Revenue VS EstimatesDGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500K 1M 1.5M
DGNX Yearly EPS VS EstimatesDGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DGNX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DGNX Price Earnings VS Forward Price EarningsDGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DGNX Per share dataDGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DGNX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIGINEX LTD

NASDAQ:DGNX (3/7/2025, 8:19:39 PM)

Premarket: 57 +2.87 (+5.3%)

54.13

-5.97 (-9.93%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.69%
Ins Owner ChangeN/A
Market Cap1.24B
AnalystsN/A
Price TargetN/A
Short Float %0.47%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 683.65
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.08
BVpS-0.69
TBVpS-0.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -565.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-602.33%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -26.28
F-Score3
WACC12.74%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-19.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.15%
OCF growth 3YN/A
OCF growth 5YN/A